查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631478

郁血性心臟衰竭设备市场规模、份额、趋势分析报告：2025 年至 2030 年按产品、地区和细分市场分類的预测

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

郁血性心臟衰竭市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球郁血性心臟衰竭设备市场预计将在2030年达到82亿美元，2025年至2030年期间的复合年增长率为6.7%。心血管疾病负担的增加是推动该领域良好成长的关键因素之一。久坐的生活方式、精神压力和食用垃圾食物的倾向是导致心血管疾病的主要因素。

美国医疗保险体係等优惠的报销政策预计将成为该行业的主要成长要素。每家公司现在都提供具有报销选项的新产品平台，使患者受益。报销适用于心室辅助人工心臟装置 (VAD)、植入式心臟整流去颤器(ICD) 和用于治疗 CHF 的心律调节器等设备。

行业相关人员专注于开发能够提供个人化护理的高度实用的产品。这些进步提供了额外的功能，可以提高准确性，增强工作流程并减少错误发生率。

郁血性心臟衰竭设备市场报告重点

  • 依产品分類的市场分为辅助人工心臟辅助装置、反搏装置、ICD、心律调节器和心臟再同步装置。 ICD 部分包括静脉内和皮下两种类型，将在 2024 年占据有利份额，其次是心律调节器部分。这是因为心臟去颤器和心律调节器是治疗心臟衰竭的第一线药物。
  • 另一方面，由于保险报销范围的增加和心室辅助人工心臟的技术进步，辅助人工心臟（VAD）部分预计在预测期内将显着增长。
  • 辅助人工心臟依植入部位不同，分为左心室辅助人工心臟（LVAD）及右心室辅助人工心臟（RVAD）。当 LVAD 和 RVAD 一起植入时，它们被称为双心室辅助装置 (BIVAD)。
  • 2024 年北美郁血性心臟衰竭设备市场占据全球市场主导地位，占有 45.6% 的份额。这是由于心血管疾病患病人口基数大，且老年人基数较大。
  • 市场参与企业正在积极致力于改善其当前的产品系列，以保持其在市场中的地位。此外，市场开发和对尚未开发国家的市场渗透预计将推动市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章郁血性心臟衰竭设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 郁血性心臟衰竭设备市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章郁血性心臟衰竭市场：按产品分類的估计和趋势分析

  • 全球郁血性心臟衰竭设备市场：产品仪表板
  • 全球郁血性心臟衰竭设备市场：产品差异分析
  • 全球郁血性心臟衰竭治疗设备市场（按产品和收益）
  • 辅助人工心臟(VAD)
    • LVAD
    • RVAD
    • 维瓦多
  • 反搏装置
  • 植入式心臟整流去颤器
    • 静脉 ICD
    • 皮下植入式心臟復律去颤器
  • 心律调节器
    • 嵌入式
    • 外部类型
  • 心臟再同步化治疗
    • 心臟再同步治疗心臟去颤器(CRT-D)
    • 心臟再同步治疗心律心律调节器(CRT-P)

第 5 章郁血性心臟衰竭市场：按地区分類的估计和趋势分析

  • 区域控制面板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争格局

  • 公司/竞争对手分类
  • 供应商概况
    • 2024 年主要企业的市场占有率分析
    • Jarvik Heart Inc.
    • ReliantHeart, Inc.
    • BIoTronik SE &Co. KG
    • Berlin Heart GmbH
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Teleflex, Inc.
Product Code: GVR-1-68038-292-1

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 8.2 billion in 2030 and is projected to grow at a CAGR of 6.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2024, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America congestive heart failure treatment devices market dominated the global market with a 45.6% share in 2024, this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Congestive Heart Failure Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in heart failure treatment
      • 3.2.1.3. Growing awareness and early detection of heart failure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of devices
      • 3.2.2.2. Complications and risks associated with device implantation
  • 3.3. Congestive Heart Failure Treatment Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Congestive Heart Failure Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. Global Congestive Heart Failure Treatment Devices Market: Product Dashboard
  • 4.2. Global Congestive Heart Failure Treatment Devices Market: Product Movement Analysis
  • 4.3. Global Congestive Heart Failure Treatment Devices Market by Product, Revenue
  • 4.4. Ventricular Assist Devices
    • 4.4.1. Ventricular assist devices market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. LVAD
      • 4.4.2.1. LVAD market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. RVAD
      • 4.4.3.1. RVAD market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. BiVAD
      • 4.4.4.1. BiVAD market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Counter Pulsation Devices
    • 4.5.1. Counter pulsation devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Implantable Cardioverter Defibrillators
    • 4.6.1. Implantable cardioverter defibrillators market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Transvenous ICDs
      • 4.6.2.1. Transvenous ICDs market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Subcutaneous ICDs
      • 4.6.3.1. Subcutaneous ICDs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Pacemakers
    • 4.7.1. Pacemakers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Implantable
      • 4.7.2.1. Implantable market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. External
      • 4.7.3.1. External market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Cardiac Resynchronization Therapy
    • 4.8.1. Cardiac resynchronization therapy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.2. Cardiac resynchronization therapy-defibrillators (CRT-D)
      • 4.8.2.1. Cardiac resynchronization therapy-defibrillators (CRT-D) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.3. Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
      • 4.8.3.1. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Congestive Heart Failure Treatment Devices Market: Regional Estimates & Trend Analysis by Product

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. Key company market share analysis, 2024
    • 6.2.2. Jarvik Heart Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. ReliantHeart, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Biotronik SE & Co. KG
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Berlin Heart GmbH
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Abbott
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Medtronic
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Boston Scientific Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Mexico congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 Germany congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 UK congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 France congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Italy congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Spain congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Denmark congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Sweden congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Norway congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 China congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 Japan congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 India congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 South Korea congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Australia congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Thailand congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Brazil congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 MEA congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 South Africa congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Congestive heart failure treatment devices market: market outlook
  • Fig. 7 Congestive heart failure treatment devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Congestive heart failure treatment devices market driver impact
  • Fig. 11 Congestive heart failure treatment devices market restraint impact
  • Fig. 12 Congestive heart failure treatment devices market: Product movement analysis
  • Fig. 13 Congestive heart failure treatment devices market: Product outlook and key takeaways
  • Fig. 14 Ventricular assist devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 LVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 RVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 BiVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Counter pulsation devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Transvenous ICDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Subcutaneous ICDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Pacemakers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Implantable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 External market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Cardiac resynchronization therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cardiac resynchronization therapy-defibrillators (CRT-D) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac resynchronization therapy-pacemakers (CRT-P) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global congestive heart failure treatment devices market: Regional movement analysis
  • Fig. 29 Global congestive heart failure treatment devices market: Regional outlook and key takeaways
  • Fig. 30 Global congestive heart failure treatment devices market share and leading players
  • Fig. 31 North America, by country
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. key country dynamics
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada key country dynamics
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico key country dynamics
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 UK key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Germany key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France key country dynamics
  • Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan key country dynamics
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India key country dynamics
  • Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina key country dynamics
  • Fig. 73 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa key country dynamics
  • Fig. 76 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia key country dynamics
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 UAE key country dynamics
  • Fig. 80 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait key country dynamics
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Market share of key market players- Congestive heart failure treatment devices market